IMP-16 in Pseudomonas putida and Pseudomonas stutzeri: potential reservoirs of multidrug resistance.
Carvalho-Assef
Ana P D'A
APD
Nosocomial Infection Research Laboratory, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Gomes
Marisa Z R
MZR
Nosocomial Infection Research Laboratory, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Silva
André R A
ARA
Hospital Infection Control Committee, Prontobaby Hospital da Criança, Rio de Janeiro, RJ, Brazil.
Werneck
Lúcia
L
Hospital Infection Control Committee, Prontobaby Hospital da Criança, Rio de Janeiro, RJ, Brazil.
Rodrigues
Caio A S
CAS
Microbiology Laboratory, Hospital dos Servidores do Estado, Rio de Janeiro, RJ, Brazil.
Souza
Maria J
MJ
Microbiology Laboratory, Hospital dos Servidores do Estado, Rio de Janeiro, RJ, Brazil.
Asensi
Marise D
MD
Nosocomial Infection Research Laboratory, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D015964:Gene Expression Regulation, Bacterial; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D007223:Infant; D016920:Meningitis, Bacterial / Q000188:drug therapy / Q000382:microbiology; D011552:Pseudomonas Infections / Q000382:microbiology*; D016958:Pseudomonas putida / Q000235:genetics / Q000378:metabolism*; D044223:Pseudomonas stutzeri / Q000235:genetics / Q000378:metabolism*; D001618:beta-Lactamases / Q000235:genetics / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D001618:beta-Lactamases; C495218:beta-lactamase IMP-16, Pseudomonas aeruginosa